Drug Database
Back to search

Netherlands· NL-110c51d1b705

Alluzience 200 Speywood-eenheden/ml oplossing voor injectie

A botulinus toxin product containing clostridium botulinum toxine type a haemagglutininecomplex, registered in Netherlands by Ipsen Pharma. The same ATC class is registered in 11 of our 19 countries.

ATC M03AX01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAlluzience 200 Speywood-eenheden/ml o…ATCM03AX01REGISTER NO.NL-110c51d1b705PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about clostridium botulinum toxine type a haemagglutininecomplexAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Botulinus toxin is registered in 11 of 19 countries.

Countries holding a registration under ATC M03AX01 (botulinus toxin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search botulinus toxin products by name

Botulinus toxin · ATC M03AX01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CLOSTRIDIUM BOTULINUM TOXINE TYPE A HAEMAGGLUTININECOMPLEX
Manufacturer
Ipsen Pharma
Country
Netherlands (NL)
ATC code
M03AX01
ATC class
Botulinus Toxin
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    125984

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

55 interactions on record for botulinus toxin.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check botulinus toxin against other medicinesHow interaction checks work

Botulinus toxin · interactions on record

55 records

  • 11 severe
  • 44 moderate

Most severe, free to view

  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • Polymyxin BA07AA05severe
  • KanamycinA07AA08severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Botulinus toxin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All botulinus toxin products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Germany · Alluzience, Bocouture

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d14ca668-db12-4dda-b885-e7c80f9b9a39
GET /v1/drugs/d14ca668-db12-4dda-b885-e7c80f9b9a39?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intramusculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h125984_smpc.pdf",
  "strength": null,
  "atc_label": "Botulinum Toxin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg125984",
  "excipients": [
    "HISTIDINE, (L-)",
    "NATRIUMCHLORIDE",
    "POLYSORBAAT 80 (E 433)",
    "SACCHAROSE",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "CLOSTRIDIUM BOTULINUM TOXINE TYPE A HAEMAGGLUTININECOMPLEX"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h125984.pdf",
  "authorised_at": "2021/10/12",
  "procedure_number": "SE/H/2019/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "125984",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about botulinus toxin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console